R Topor-Madry1, B Wojtyniak2, K Strojek3, D Rutkowski4, S Bogusławski5, A Ignaszewska-Wyrzykowska6, P Jarosz-Chobot7, M Czech8, A Kozierkiewicz9, K Chlebus10, T Jędrzejczyk6, M Mysliwiec11, J Polanska12, M J Wysocki2, T Zdrojewski6. 1. Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow. 2. National Institute of Public Health - National Institute of Hygiene, Warsaw. 3. Department of Internal Diseases, Diabetology and Cardiometabolic Diseases, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice. 4. National Health Fund, Warsaw. 5. PEX PharmaSequence LLC, Warsaw. 6. Department of Preventive Medicine and Medical Education, Medical University of Gdansk, Gdansk. 7. Department of Children's Diabetology, Medical University of Silesia, Katowice. 8. Medical University in Warsaw, Warsaw. 9. Jaspers, Warsaw. 10. Department of Cardiology, Clinical Center of Cardiology, Medical University of Gdansk, Gdansk. 11. Chair of Pediatrics, Diabetology and Endocrinology, Medical University of Gdansk, Gdansk, Gdansk. 12. Data Mining Group, Silesian University of Technology, Gliwice, Poland.
Abstract
AIMS: To assess the number of people with diabetes in Poland using combined national sources and to evaluate the usefulness of data from an insurance system for epidemiological purposes. METHODS: The data were collected from four sources: 1) 2013 all-billing records of the national insurance system comprising people of all age groups undergoing procedures or receiving services in primary healthcare, specialist practices and hospitals and also those receiving drugs; 2) an epidemiological study, NATPOL, that involved the assessment of people with undiagnosed diabetes; 3) the RECEPTOmetr Sequence study on prescriptions; and 4) regional child diabetes registries. RESULTS: In 2013, 1.76 million people (0.98 million women and 0.79 million men) had medical consultations (coded E10-E14) and 2.13 million people (1.19 million women and 0.94 million men) purchased drugs or strip tests for diabetes. A total of 0.04 million people who used medical services did not buy drugs. In total, the number of people with diabetes in the insurance system was 2.16 million (1.21 million women and 0.95 million men), which corresponds to 6.1% (95% CI 6.11-6.14) of women and 5.1% (95% CI 5.12-5.14) of men. Including undiagnosed cases, the total number of people with diabetes in Poland was 2.68 million in 2013. CONCLUSION: The estimated prevalence of diabetes (diagnosed and undiagnosed cases) in Poland is 6.97%. Data from the national insurance system with full coverage of the population can be treated as a reliable source of information on diseases with well-defined diagnosis and treatment methods, combined with an assessment of the number of undiagnosed individuals.
AIMS: To assess the number of people with diabetes in Poland using combined national sources and to evaluate the usefulness of data from an insurance system for epidemiological purposes. METHODS: The data were collected from four sources: 1) 2013 all-billing records of the national insurance system comprising people of all age groups undergoing procedures or receiving services in primary healthcare, specialist practices and hospitals and also those receiving drugs; 2) an epidemiological study, NATPOL, that involved the assessment of people with undiagnosed diabetes; 3) the RECEPTOmetr Sequence study on prescriptions; and 4) regional childdiabetes registries. RESULTS: In 2013, 1.76 million people (0.98 million women and 0.79 million men) had medical consultations (coded E10-E14) and 2.13 million people (1.19 million women and 0.94 million men) purchased drugs or strip tests for diabetes. A total of 0.04 million people who used medical services did not buy drugs. In total, the number of people with diabetes in the insurance system was 2.16 million (1.21 million women and 0.95 million men), which corresponds to 6.1% (95% CI 6.11-6.14) of women and 5.1% (95% CI 5.12-5.14) of men. Including undiagnosed cases, the total number of people with diabetes in Poland was 2.68 million in 2013. CONCLUSION: The estimated prevalence of diabetes (diagnosed and undiagnosed cases) in Poland is 6.97%. Data from the national insurance system with full coverage of the population can be treated as a reliable source of information on diseases with well-defined diagnosis and treatment methods, combined with an assessment of the number of undiagnosed individuals.
Authors: Anna Maria Bednarek; Aleksander Jerzy Owczarek; Anna Chudek; Agnieszka Almgren-Rachtan; Katarzyna Wieczorowska-Tobis; Magdalena Olszanecka-Glinianowicz; Jerzy Chudek Journal: Int J Environ Res Public Health Date: 2022-08-02 Impact factor: 4.614
Authors: Jarosław Pasek; Sebastian Szajkowski; Piotr Oleś; Grzegorz Cieślar Journal: Int J Environ Res Public Health Date: 2022-08-24 Impact factor: 4.614
Authors: Paweł Rajewski; Dorota Zarębska-Michaluk; Ewa Janczewska; Andrzej Gietka; Włodzimierz Mazur; Magdalena Tudrujek-Zdunek; Krzysztof Tomasiewicz; Teresa Belica-Wdowik; Barbara Baka-Ćwierz; Dorota Dybowska; Waldemar Halota; Beata Lorenc; Marek Sitko; Aleksander Garlicki; Hanna Berak; Andrzej Horban; Iwona Orłowska; Krzysztof Simon; Łukasz Socha; Marta Wawrzynowicz-Syczewska; Jerzy Jaroszewicz; Zbigniew Deroń; Agnieszka Czauż-Andrzejuk; Jolanta Citko; Rafał Krygier; Anna Piekarska; Łukasz Laurans; Witold Dobracki; Jolanta Białkowska; Olga Tronina; Magdalena Wietlicka-Piszcz; Małgorzata Pawłowska; Robert Flisiak Journal: J Clin Med Date: 2022-01-13 Impact factor: 4.241